Soichiro Morinaga

Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)

Katsuhiko Uesaka, Narikazu Boku, Akira Fukutomi et al. · The Lancet · 2016 · 1.1K citations

Surgical Oncology, Oncology, Pancreatic Cancer +6

Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial

Kohei Nakachi, Masafumi Ikeda, Masaru Konishi et al. · The Lancet · 2023 · 214 citations

Surgical Oncology, Gastrointestinal Oncology, Medicine +9

The clinical significance of SWI/SNF complex in pancreatic cancer

Masakatsu Numata, Soichiro Morinaga, Takuo Watanabe et al. · International Journal of Oncology · 2012 · 88 citations · Full text

Tumor Biology, Surgical Oncology, Pancreatic Cancer +11

The clinicopathological features of colorectal mucinous adenocarcinoma and a therapeutic strategy for the disease

Masakatsu Numata, Manabu Shiozawa, Takuo Watanabe et al. · World Journal of Surgical Oncology · 2012 · 81 citations · Full text

Randomized phase III trial of adjuvant chemotherapy with gemcitabine versus S-1 for patients with resected pancreatic cancer (JASPAC-01 study).

Katsuhiko Uesaka, Akira Fukutomi, Narikazu Boku et al. · Journal of Clinical Oncology · 2013 · 66 citations

Oral Fluoropyrimidine, Surgical Oncology, Oncology +15